Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by BudFoxx2020on Oct 24, 2023 8:54am
187 Views
Post# 35697847

RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE FinancingI highly doubt there ever was anything, JV, partnership, takeover, etc.  Management was looking for it.  But it was the promoters and pumptards here that really blew it out of proportion.  It really is not rocket science.  The last few PP's were never filled, no one wants to plunk anymore money after 20 years, management had to use their own money to fill the last PP.  This LIFE financing is the last attempt to sought out the desperate cash they need to keep the lights on.  Research Capital or formerly Mackie is only here to suck the last dollars out of this company.  Just research Mackie, they are very familiar with OSC.  Lolol.  This financing and the next 7 days will dictate where the company is headed.  But form my experience, With RC stepping in, it is just a matter of time.  Ofcourse this is just my opinion.  Good luck.   

Anyways, If this does not pan out, I really hope some of these promoters and pumptards here are held responsible.  Especially Sciencfirst / Bencro, who conveniently dissappeared.  Lolololol, and like I said that was the biggest red flag.  Good luck, I would advise not watching the TLT ticker today.  Lol. 

Here are a few of my post on the matter which was obviously burried by the promoters.   

Comment by BudFoxx2020on Oct 23, 2023 7:51pm

Rofl, I told you there will be a dilution.  Remember how the promoters were spinning their nonsense about how there won't be no dilution, they don't need money, how warrants will be in play.  Yep, just another BS they spun every year.  Do people even know what this is.  Here is my gist of it.  Correct me if I am wrong.  This is a last ditch attempt at funding to keep this going.  Seems like no one was interested in another private placement.  So they went with LIFE financing.  It looks like Research Capital will be running this show.  Basically, RC will be hitting all their clients to take part in this funding.  Lots of cold calls coming.  The point of this financing is to try and sell as much shares as they can.   The good news is they will probably fill this with the client base they have.  The bad news there is no resale restriction.  The good news again, they could be gearing up for a pump in stock price and then a dump.  So there might be some great short term opportunity to make a quick buck.  The bad news, RC is going to squeeze the last dollar out of this company.  Just watch.  Good luck going forward.  Just my 0.02 cents.  Cheers.  

Comment by BudFoxx2020on Oct 23, 2023 8:31pm

Yep at 0.22 cents that is a straight 15% haircut.  Add in the panicky people selling tomorrow at open, easily a 20%+ haricut in share price tomorrow before the markets even open.  The point of this dilution is not to to get filled but to sell as much as you can to the public, which RC will be doing.  I wouldn't be suprised to see the promoters ramp up their promo campaign this week starting tomorrow.  We might even see SF back.  Lolololololol.  Keep in mind they are trying to raise a minimum of $3.5 milli, like I mentioned earlier, $3.5 milli is easily doable with a firm like RC, if not they can just fill the rest.  The bad thing no resale restriction, they can dump anytime they want.  Which means share price will always be anchored down by RC.  RC will suck the last dollar out of this company.  Once again just my 0.02 cents. 
<< Previous
Bullboard Posts
Next >>